Cascade Aids Project
Cascade Aids Project's latest filing in the PeerBasis snapshot reports a Part VII D + F figure of $210,566 for Emily Gilliland, Former Interim Ceo (FY 2024). Column F can include amounts from the filing and related organizations.
After indexing supported filing years to 2025 comparison dollars, the subject figure is $216,107. It is higher than the D + F figure for 10 of 51 peer organizations selected under the disclosed tier Same NTEE major group (G), nationwide + size band 0.77–1.3× revenue (approximately 20%; median $317,569). This is descriptive, not a reasonableness conclusion.
Preparing executive-pay materials for this board?
Review the selected comparables for Cascade Aids Project, then prepare a source-linked report and bracketed documentation worksheet for the board to verify and complete.
Review the peer setSelected peer organizations
Actual selection tier: Same NTEE major group (G), nationwide + size band 0.77–1.3× revenue. Displayed D + F figures from supported filing years are indexed to 2025 comparison dollars with BLS CPI-U; a nationwide tier also uses 2024 BEA RPP as a consumer price-level proxy when both the subject and peer have supported state codes. Unsupported state codes receive no interstate adjustment. Comparison values can differ from the raw filing. Column F may include related-organization amounts.
| Organization | State | Revenue | D + F (2025 dollars) |
|---|---|---|---|
| Autism Opportunities Foundation | MN | $29,447,161 | $444,754 |
| Accessia Health | VA | $29,752,502 | $637,755 |
| Unified Community Connections Inc | MD | $29,870,654 | $436,162 |
| Easter Seals Of Greater Houston Inc | TX | $29,888,569 | $385,156 |
| Central Association For The Blind Inc | NY | $29,950,114 | $278,434 |
| The Multiple Myeloma Research | CT | $29,101,414 | $504,301 |
| Evergreen Center Inc | MA | $30,164,928 | $359,971 |
| Hemostasis And Thrombosis Center Of | NV | $28,961,379 | $238,610 |
View the organization record and available filings on ProPublica